James Edgemond, CFO AND TREASURER at UNITED THERAPEUTICS Corp (UTHR), sold 10,000 shares at $568.60 ($5.8M) on 2026-05-04, disclosed to the SEC on 2026-05-05.
Scheduled sale ($5.8M) by CFO AND TREASURER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $568.60 | 80 | $45K | 0.8% |
| 2 | $570.06 | 80 | $46K | 0.8% |
| 3 | $571.00 | 40 | $23K | 0.4% |
| 4 | $572.40 | 480 | $275K | 4.8% |
| 5 | $573.82 | 153 | $88K | 1.5% |
| 6 | $574.84 | 487 |
| $280K |
| 4.9% |
| 7 | $575.75 | 2,436 | $1.4M | 24.3% |
| 8 | $576.66 | 3,005 | $1.7M | 30.0% |
| 9 | $577.54 | 719 | $415K | 7.2% |
| 10 | $579.13 | 1,160 | $672K | 11.6% |
| 11 | $580.26 | 440 | $255K | 4.4% |
| 12 | $581.28 | 520 | $302K | 5.2% |
| 13 | $582.29 | 400 | $233K | 4.0% |
| Total | $576.93 avg | 10,000 | $5.8M | 100% |
| Filing → |
| UTHR | SELL | 2026-06-16 | $5.5M | — | Filing → |
| UTHR | SELL | 2026-06-12 | $5.5M | — | Filing → |
| UTHR | SELL | 2026-06-09 | $5.5M | — | Filing → |